Management of Intra-abdominal Infections due to Carbapenemase-Producing Organisms.

Curr Infect Dis Rep

Department of Sciences for Health Promotion and Mother-Child Care "G. D'Alessandro", University of Palermo, Via del Vespro 127, 90127, Palermo, Italy,

Published: October 2014

The prevalence of bacterial resistance to carbapenem antibiotics continues to increase because of bacteria producing metallo-β-lactamases (MBL), called carbapenemase-producing organisms (CPO). Enterobacteriaceae, which can be a common cause of intra-abdominal infections (IAIs), have become carbapenem-resistant Enterobacteriaceae (CRE). Updated international guidelines for the treatment of both IAIs and IAIs due to CRE have been published. Given the multifaceted nature of these infections, these recommendations have been jointly reviewed and endorsed by the Surgical Society and the Association of Medical Microbiology and Infectious Disease. The aims of this review are to summarize the general and new generation of multimodal procedure to manage IAIs due to CRE and review the data available on the combination of interventions to reduce CRE. Future research should focus on the development of novel and safe antimicrobial therapies and the quantification of the incremental effect of infection control programmes and new methods to rapidly detect pathogens before patients enter the surgical setting.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11908-014-0428-7DOI Listing

Publication Analysis

Top Keywords

intra-abdominal infections
8
carbapenemase-producing organisms
8
iais cre
8
management intra-abdominal
4
infections carbapenemase-producing
4
organisms prevalence
4
prevalence bacterial
4
bacterial resistance
4
resistance carbapenem
4
carbapenem antibiotics
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!